{"cik":2046386,"taxonomy":"us-gaap","tag":"AllocatedShareBasedCompensationExpense","label":"Share-based Payment Arrangement, Expense","description":"Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.","entityName":"Medline Inc.","units":{"USD":[{"start":"2023-01-01","end":"2023-12-31","val":73000000,"accn":"0002046386-26-000009","fy":2025,"fp":"FY","form":"10-K","filed":"2026-02-25","frame":"CY2023"},{"start":"2024-01-01","end":"2024-12-31","val":61000000,"accn":"0002046386-26-000009","fy":2025,"fp":"FY","form":"10-K","filed":"2026-02-25","frame":"CY2024"},{"start":"2025-01-01","end":"2025-03-29","val":19000000,"accn":"0002046386-26-000026","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-06","frame":"CY2025Q1"},{"start":"2025-01-01","end":"2025-06-28","val":34000000,"accn":"0002046386-26-000051","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-05"},{"start":"2025-03-30","end":"2025-06-28","val":15000000,"accn":"0002046386-26-000051","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-05","frame":"CY2025Q2"},{"start":"2025-01-01","end":"2025-12-31","val":79000000,"accn":"0002046386-26-000009","fy":2025,"fp":"FY","form":"10-K","filed":"2026-02-25","frame":"CY2025"},{"start":"2026-01-01","end":"2026-03-28","val":23000000,"accn":"0002046386-26-000026","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-06","frame":"CY2026Q1"},{"start":"2026-01-01","end":"2026-06-27","val":52000000,"accn":"0002046386-26-000051","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-05"},{"start":"2026-03-29","end":"2026-06-27","val":29000000,"accn":"0002046386-26-000051","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-05","frame":"CY2026Q2"}]}}